Savitz Ryan
SEC insider (Form 3/4/5 filer). CIK 0001992324. EVP, CFO & CBO at Dianthus Therapeutics, Inc. /DE/ (DNTH). 23 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in NEW YORK, NY.
Companies Savitz Ryan has filed insider reports for
- Dianthus Therapeutics, Inc. /DE/ (DNTH): Officer, EVP, CFO & CBO
Savitz Ryan
CIK: 0001992324
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dianthus Therapeutics, Inc. /DE/
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Jul 9, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect10.4K shares at avg. $100.22$1.0M - Jul 9, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect31.2K shares at avg. $21.77$680K - Jul 9, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect5.6K shares at avg. $101.97$568K - Jul 9, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect15.3K shares at avg. $101.24$1.6M - Apr 9, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect8.2K shares at avg. $89.84$739K - Apr 9, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect8.2K shares at avg. $17.88$147K - Mar 31, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect1.5K shares at avg. $80.25$119K - Mar 31, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect21.8K shares at avg. $78.86$1.7M - Mar 31, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect74.4K shares at avg. $8.44$628K - Mar 31, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect59.8K shares at avg. $83.90$5.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 10,354 | $100.22 | $1,037,678 | Direct |
| Jul 9, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 31,249 | $21.77 | $680,291 | Direct |
| Jul 9, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 5,566 | $101.97 | $567,565 | Direct |
| Jul 9, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 15,329 | $101.24 | $1,551,908 | Direct |
| Apr 9, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 8,224 | $89.84 | $738,844 | Direct |
| Apr 9, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 8,224 | $17.88 | $147,045 | Direct |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 1,485 | $80.25 | $119,171 | Direct |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 21,825 | $78.86 | $1,721,120 | Direct |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 74,367 | $8.44 | $627,657 | Direct |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 59,800 | $83.90 | $5,017,220 | Direct |
1-10 of 23 transactions